FDA approves InspireMD's CGuard Prime micromesh stent for TCAR procedures

Photo: Operator at a C-arm. Navy Medicine / Unsplash

1. FDA approves InspireMD's CGuard Prime micromesh stent for TCAR procedures

The approval extends the MicroNet-covered stent beyond transfemoral carotid stenting.

InspireMD said Nov. 12 that the FDA approved its PMA supplement for the CGuard Prime TransCarotid Stent System for transcarotid artery revascularization, including an 80 cm delivery system used with an embolic protection system specified in the labeling [1]. The self-expanding nitinol stent is covered by a permanent protective micromesh, and in the 50-patient, 11-site CGUARDIANS II pivotal trial of high-surgical-risk patients, there were no deaths, strokes, heart attacks or stent thromboses at 30 days, with 100% acute device success [1]. The company estimates more than 35,000 TCAR procedures are performed in the U.S. each year and says the approval doubles the platform's addressable market [1].

2. CDC confirms six measles deaths in 2026 as cases pass 5,000 for the first time since 1991

A PAHO commission is expected to rule on U.S. elimination status within days.

The CDC's website on Nov. 12 confirmed six measles-related deaths in the United States this year, double the 2025 toll, as cases rose above 5,000 for the first time since 1991, Reuters reported [2]. Pennsylvania, the hardest-hit state, had confirmed six measles-associated deaths as of Nov. 4, Wisconsin reported an infant's death and New York its first in more than 30 years; the CDC did not say which states its six deaths occurred in, having switched to National Center for Health Statistics mortality data [2]. The Pan American Health Organization's expert commission was expected to decide in coming days whether the U.S., declared measles-free in 2000, keeps that status [2].

3. Florida man pleads guilty to $42 million DME and genetic-testing Medicare fraud

Proceeds funded a 47-foot yacht named "The Rogue Shark."

Chad Monroe, 48, of Tarpon Springs, pleaded guilty to conspiracy to commit health care fraud and wire fraud, the Justice Department said Nov. 13 [3]. Through three durable medical equipment companies whose ownership he concealed, conspirators submitted more than $26 million in claims to Medicare, Medicare Advantage plans and TRICARE for braces beneficiaries did not want or need, and Monroe paid purported telemedicine companies kickbacks for doctors' orders while collecting more than $15 million in kickbacks from laboratories for genetic-testing orders [3]. The government seized the yacht, valued at more than $600,000, and more than $1 million; he faces up to 10 years on the conspiracy count and 30 years on the wire fraud count [3].

4. Reuters: FDA shelves Commissioner's National Priority Voucher pilot; HHS says it is ongoing

No new vouchers have been issued since Marty Makary's departure in May.

Reuters reported Nov. 12, citing anonymous sources, that the FDA has shelved the Commissioner's National Priority Voucher pilot launched in June 2025 to cut drug review times to one to two months, with applications remaining open but not moving forward [4]. Of 22 drugs awarded vouchers, 12 have been approved, five of them after Makary left, and career FDA scientists have reportedly resumed oversight of review timelines for the nine drugs still in the program [4]. HHS disputed the report, with spokesperson Emily Hilliard saying the pilot is ongoing and that the agency is reviewing feedback from a June 4 public hearing [4].

Digest references

  1. InspireMD, "InspireMD Receives FDA Approval for CGuard Prime TransCarotid Stent System for TCAR" (Form 8-K exhibit), Nov. 12, 2026. sec.gov

  2. Reuters (via Yahoo News), "US CDC confirms six measles deaths in 2026," Nov. 12, 2026. yahoo.com

  3. U.S. Department of Justice, "Florida Man Pleads Guilty to $42M Durable Medical Equipment and Cancer Genetic Testing Fraud," Nov. 13, 2026. justice.gov

  4. Pharmacy Times, "FDA Reportedly Shelves Commissioner's National Priority Voucher Program," Nov. 12, 2026. pharmacytimes.com

Katie Coffee

Professional photographer, Medical journalist, Business Development & Head of Marketing at Innovative Vascular Institute, from Louisiana, to Nashville. Medical PR

https://katiecoffeephoto.com
Previous
Previous

U.S. reported to lose measles elimination status after 26 years

Next
Next

FDA approves Contego's Neuroguard IEP Direct system for carotid stenting with flow reversal and filter